Group 1: Investor Meeting Announcement - The company will hold a half-year performance briefing on August 13, 2025, from 10:00 to 11:00 AM [2][8] - Investors can submit questions from August 6 to August 12, 2025, via the Shanghai Stock Exchange Roadshow Center or the company's email [2][9] - The meeting will be conducted in an interactive online format, allowing for real-time communication with investors [3] Group 2: Attendance and Participation - Key personnel attending the meeting include the Chairman, General Manager, Independent Director, and other senior management [4] - Investors can participate in the meeting by logging into the Shanghai Stock Exchange Roadshow Center [6][7] - The meeting will be accessible online, and investors can view the main content afterward [10] Group 3: Share Buyback Progress - The company approved a share buyback plan on September 5, 2024, with a maximum price of RMB 62.76 per share and a total buyback fund between RMB 150 million and RMB 300 million [12] - As of July 31, 2025, the company has repurchased 3.540021 million shares, accounting for 0.5890% of the total share capital, with a total expenditure of approximately RMB 150.07 million [15] - The purpose of the buyback has been adjusted from employee stock ownership plans to reducing the company's registered capital [13]
甘李药业股份有限公司关于召开2025年半年度业绩说明会的公告